Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Assets (2019 - 2023)

Historic Current Assets for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $375.6 million.

  • ADC Therapeutics' Current Assets fell 1426.64% to $375.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $375.6 million, marking a year-over-year decrease of 1426.64%. This contributed to the annual value of $435.0 million for FY2022, which is 8272462.08% up from last year.
  • ADC Therapeutics' Current Assets amounted to $375.6 million in Q3 2023, which was down 1426.64% from $412.8 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Current Assets ranged from a high of $568.4 million in Q3 2021 and a low of $122606.0 during Q4 2019
  • In the last 5 years, ADC Therapeutics' Current Assets had a median value of $403.6 million in 2021 and averaged $342.2 million.
  • In the last 5 years, ADC Therapeutics' Current Assets surged by 11214065.45% in 2021 and then plummeted by 2292.53% in 2022.
  • Quarter analysis of 5 years shows ADC Therapeutics' Current Assets stood at $122606.0 in 2019, then skyrocketed by 313.05% to $506419.0 in 2020, then soared by 94693.87% to $480.1 million in 2021, then fell by 9.39% to $435.0 million in 2022, then dropped by 13.65% to $375.6 million in 2023.
  • Its Current Assets was $375.6 million in Q3 2023, compared to $412.8 million in Q2 2023 and $380.0 million in Q1 2023.